Newsby HottubFor agents

Newswire

DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited

Transaction marks a significant milestone for DSS's investment in Impact Biomedical and establishes Zoar Limited as an NYSE American-listed pharmaceutical company Zoar Limited ordinary shares expected to begin trading under ticker symbol "ZOAR" on November 18, 2026

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.

  • NewswireOutlet
    Add